68 related articles for article (PubMed ID: 21749360)
21. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients.
Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A
Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155
[TBL] [Abstract][Full Text] [Related]
22. Chronic lymphocytic leukaemia Is terminal del(14)(q24) a new marker for prognostic stratification?
La Starza R; Barba G; Matteucci C; Crescenzi B; Romoli S; Pierini V; Beacci D; Cantaffa R; Martelli MF; Mecucci C
Leuk Res; 2006 Dec; 30(12):1569-72. PubMed ID: 16650893
[TBL] [Abstract][Full Text] [Related]
23. Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia.
Hewamana S; Lin TT; Rowntree C; Karunanithi K; Pratt G; Hills R; Fegan C; Brennan P; Pepper C
J Clin Oncol; 2009 Feb; 27(5):763-9. PubMed ID: 19124804
[TBL] [Abstract][Full Text] [Related]
24. A scoring system based on the expression of six surface molecules allows the identification of three prognostic risk groups in B-cell chronic lymphocytic leukemia.
Zucchetto A; Bomben R; Dal Bo M; Sonego P; Nanni P; Rupolo M; Bulian P; Dal Maso L; Del Poeta G; Del Principe MI; Degan M; Gattei V
J Cell Physiol; 2006 May; 207(2):354-63. PubMed ID: 16331666
[TBL] [Abstract][Full Text] [Related]
25. Missense mutations located in structural p53 DNA-binding motifs are associated with extremely poor survival in chronic lymphocytic leukemia.
Trbusek M; Smardova J; Malcikova J; Sebejova L; Dobes P; Svitakova M; Vranova V; Mraz M; Francova HS; Doubek M; Brychtova Y; Kuglik P; Pospisilova S; Mayer J
J Clin Oncol; 2011 Jul; 29(19):2703-8. PubMed ID: 21606432
[TBL] [Abstract][Full Text] [Related]
26. Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.
Robledo C; García JL; Caballero D; Conde E; Arranz R; Flores T; Grande C; Rodríguez J; García E; Sáez AI; González M; Gutiérrez NC; Piris MA; Hernández JM;
Cancer; 2009 Aug; 115(16):3728-37. PubMed ID: 19517471
[TBL] [Abstract][Full Text] [Related]
27. Two germ line polymorphisms of the tumour suppressor gene p53 may influence the biology of chronic lymphocytic leukaemia.
Kochethu G; Delgado J; Pepper C; Starczynski J; Hooper L; Krishnan S; Fegan C; Pratt G
Leuk Res; 2006 Sep; 30(9):1113-8. PubMed ID: 16458962
[TBL] [Abstract][Full Text] [Related]
28. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
Rasi S; Spina V; Bruscaggin A; Vaisitti T; Tripodo C; Forconi F; De Paoli L; Fangazio M; Sozzi E; Cencini E; Laurenti L; Marasca R; Visco C; Xu-Monette ZY; Gattei V; Young KH; Malavasi F; Deaglio S; Gaidano G; Rossi D
Br J Haematol; 2011 Feb; 152(3):284-94. PubMed ID: 21121903
[TBL] [Abstract][Full Text] [Related]
29. Abnormal serum free light chain ratios are associated with poor survival and may reflect biological subgroups in patients with chronic lymphocytic leukaemia.
Pratt G; Harding S; Holder R; Fegan C; Pepper C; Oscier D; Gardiner A; Bradwell AR; Mead G
Br J Haematol; 2009 Jan; 144(2):217-22. PubMed ID: 19016722
[TBL] [Abstract][Full Text] [Related]
30. [Trisomy 8 in chronic lymphocytic leukemia].
Cao X; Xu W; Liu Q; Zhu DX; Qiao C; Wu YJ; Qiu HX; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Aug; 26(4):443-5. PubMed ID: 20017313
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
32. Genomic approaches to chronic lymphocytic leukemia.
Improgo MR; Brown JR
Hematol Oncol Clin North Am; 2013 Apr; 27(2):157-71. PubMed ID: 23561468
[TBL] [Abstract][Full Text] [Related]
33. FISH-ing for answers: Can genomic arrays add to our understanding of disease biology in low-risk chronic lymphocytic leukaemia?
Rhodes J
Br J Haematol; 2023 Sep; 202(5):922-924. PubMed ID: 37519004
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of c.7544-7545 delCT NOTCH1 mutation in chronic lymphocytic leukaemia.
Del Poeta G; Dal Bo M; Del Principe MI; Pozzo F; Rossi FM; Zucchetto A; Bomben R; Degan M; Rasi S; Rossi D; Bulian P; Gaidano G; Amadori S; Gattei V
Br J Haematol; 2013 Feb; 160(3):415-8. PubMed ID: 23167503
[No Abstract] [Full Text] [Related]
35. Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH.
Mian M; Rinaldi A; Mensah AA; Rossi D; Ladetto M; Forconi F; Marasca R; Uhr M; Stussi G; Kwee I; Cavalli F; Gaidano G; Zucca E; Bertoni F
Ann Oncol; 2013 May; 24(5):1378-84. PubMed ID: 23372049
[TBL] [Abstract][Full Text] [Related]
36. del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia.
Jondreville L; Dehgane L; Doualle C; Smagghe L; Grange B; Davi F; Lerner LK; Garnier D; Bravetti C; Tournilhac O; Roos-Weil D; Boubaya M; Chapiro E; Susin SA; Nguyen-Khac F
Leukemia; 2023 Nov; 37(11):2221-2230. PubMed ID: 37752286
[TBL] [Abstract][Full Text] [Related]
37. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of
Ondroušková E; Bohúnová M; Závacká K; Čech P; Šmuhařová P; Boudný M; Oršulová M; Panovská A; Radová L; Doubek M; Plevová K; Jarošová M
Front Oncol; 2022; 12():859618. PubMed ID: 35814434
[TBL] [Abstract][Full Text] [Related]
38. "Double-Hit" Chronic Lymphocytic Leukemia, Involving the
Nguyen-Khac F
Front Oncol; 2021; 11():826245. PubMed ID: 35096627
[TBL] [Abstract][Full Text] [Related]
39. Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome.
Sun C; Xu J; Zhang B; Huang H; Chen L; Yan H; Xu A; Zhao F; Huang D; Liu L; Li J; Hu Y
Blood Adv; 2021 Jun; 5(12):2563-2568. PubMed ID: 34129019
[TBL] [Abstract][Full Text] [Related]
40. Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin.
Ghetti M; Vannini I; Storlazzi CT; Martinelli G; Simonetti G
Mol Cancer; 2020 Mar; 19(1):69. PubMed ID: 32228602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
